Figure 2
From: Hydroxyurea and sickle cell anemia: effect on quality of life
Selected parameters from MOS Short-Form SF-36 Health Quality of Life and the Profile of Mood States in adults with moderate-severe sickle cell anemia, treated with hydroxyurea or placebo for two years, and classified according to 2-year Hb-F response or placebo (short dashes). High responders (solid line) were above the 50th percentile of HbF change from baseline to 2-years in the hydroxyurea group; low responders (long dashes) were below the 50th percentile. Mean quality of life measures and the standard error of the mean are shown.